Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Linezolid-Induced Thrombocytopenia in ICU Patients
NCT05944458Phase 4Completed
- Sponsor
- Helwan University
- Start
- Aug 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in Thrombocytopenia, sponsored by Helwan University. Started Aug 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05944458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944458.